Peripheral Blood B Cell Distribution of Patients with Multiple Sclerosis

Joob Beuy, Viroj Wiwanitkit

DOI: 10.4274/tnd.86977

Issue: 2018, Volume 24 - Issue 2
0 254

Efficacy of Focused Ultrasound Thalamotomy in Essential Tremor

Halil Önder

DOI: 10.4274/tnd.60963

Issue: 2018, Volume 24 - Issue 1
0 253

A New Treatment Option for Amyotrophic Lateral Sclerosis: Edaravone

Erdi Şahin

DOI: 10.4274/tnd.90698

Issue: 2018, Volume 24 - Issue 1
0 245

Mortality in Patients with Multiple Sclerosis

Sümeyra Şamlı, Murat Kürtüncü

DOI: 10.4274/tnd.15921

Issue: 2018, Volume 24 - Issue 1
0 340

Fampridine Therapy in Multiple Sclerosis: We Should Think Twice!

Mohamed S A Mohamed

DOI: 10.4274/tnd.65882

Issue: 2018, Volume 24 - Issue 1
0 222

Fingolimod for the Treatment of Relapsing-Remitting Multiple Sclerosis

Burcu Altunrende, Erkingül Birday, Mithat Kasap, Gülşen Akman Demir

DOI: 10.4274/tnd.62144

Issue: 2017, Volume 23 - Issue 4
0 331

Quality of Life, Coping, and Social Support in Patients with Multiple Sclerosis: A Pilot Study

Oğuzhan Zengin, Ercüment Erbay, Buğra Yıldırım, Özgür Altındağ

DOI: 10.4274/tnd.37074

Issue: 2017, Volume 23 - Issue 4
0 402

Flow Cytometry Analysis of Peripheral Blood B Cell Distribution of Patients with Multiple Sclerosis

Vuslat Yılmaz, Deniz Ak Tura, Canan Ulusoy, Duygu Özkan Yaşargün, Suzan Adın Çınar, Recai Türkoğlu

DOI: 10.4274/tnd.87523

Issue: 2017, Volume 23 - Issue 4
0 283

Neuroradiologic Findings of Intracranial Hypotension: Two Cases

Özlem Kayım Yıldız, Recep Dönmez, Şeyda Figül Gökçe, Aslı Bolayır, Burhanettin Çiğdem, Hatice Balaban, Bülent Yıldız, Ertuğrul Bolayır, Suat Topaktaş

DOI: 10.4274/tnd.47568

Issue: 2017, Volume 23 - Issue 4
0 264

Acute Spinal Pseudoathetosis

Mehmet Fevzi Öztekin, Dilara Mermi Dibek

DOI: 10.4274/tnd.27167

Issue: 2017, Volume 23 - Issue 4
0 225

Weight Loss and Fingolimod

Nefati Kıylıoğlu

DOI: 10.4274/tnd.87528

Issue: 2017, Volume 23 - Issue 4
0 210

The Effect of Ocrelizumab in the Treatment of Multipl Sclerosis

Şenay Yıldız Çelik

DOI: 10.4274/tnd.71354

Issue: 2017, Volume 23 - Issue 3
0 240

Amiselimod: A New Oral Agent in the Treatment of Multiple Sclerosis

Ahmed Serkan Emekli

DOI: 10.4274/tnd.90018

Issue: 2017, Volume 23 - Issue 3
0 208

The Predictive Role of NEDA in the Long-Term Course of Multiple Sclerosis

Özgü Kizek

DOI: 10.4274/tnd.65391

Issue: 2017, Volume 23 - Issue 1
0 234

Does Serum Vitamin D Level During Pregnancy Influence the Risk of Multiple Sclerosis?

Tuncay Gündüz

DOI: 10.4274/tnd.28566

Issue: 2016, Volume 22 - Issue 4
0 247

Effect of Early Treatment of Hypertension in Acute Cerebral Hemorrhage: New Evidences

Tuncay Gündüz

DOI: 10.4274/tnd.82642

Issue: 2016, Volume 22 - Issue 4
0 287

Relapses in Multiple Sclerosis: Definition, Pathophysiology, Features, Imitators, and Treatment

Serhan Sevim

DOI: 10.4274/tnd.75318

Issue: 2016, Volume 22 - Issue 3
0 355

Cognitive Impairment in Young Multiple Sclerosis and Essential Tremor Patients: A Comparative Study

Hakan Serdar Şengül, Yıldızhan Şengül, Selma Yücel, Hulki Forta

DOI: 10.4274/tnd.46704

Issue: 2016, Volume 22 - Issue 3
0 325

The Acute Treatment of Migraine Attack in Adults and American Headache Society Evidence Assessment of Migraine Pharmacotherapies

Pınar Yalınay Dikmen

DOI: 10.4274/tnd.93753

Issue: 2016, Volume 22 - Issue 1
0 363

A Rare Guillain Barre Syndrome Variant: Facial Diplegia Paresthesia

Emel Oguz Akarsu, Destina Yalçın, Reyhan Sürmeli, Ahmet Demir, Gülin Sünter, Yunus Diler

DOI: 10.4274/tnd.70456

Issue: 2015, Volume 21 - Issue 4
0 310